Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2683_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Series Editors’ foreword
- •Prefaces
- •Acknowledgements
- •Series Editors’ acknowledgements
- •History of the presenting complaint (HPC)
- •Past medical history (PMH)
- •Medications and allergies (DHX)
- •Family history (FHX)
- •Social history (SHX)
- •Systems review (SR)
- •General symptoms
- •Fatigue
- •Appetite
- •Weight change
- •Sweats
- •Pruritus (itching)
- •Sleep pattern
- •Cardiovascular symptoms
- •Chest pain
- •Shortness of breath (dyspnoea) and exercise tolerance
- •Loss of consciousness (syncope)
- •Palpitations
- •Ankle and calf swelling
- •Calf, thigh or buttock pain on exertion (claudication)
- •Respiratory symptoms
- •Dyspnoea
- •Cough
- •Sputum
- •Chest pain
- •Wheeze
- •Hoarse voice
- •Gastrointestinal disease
- •Abdominal pain
- •Dysphagia
- •Nausea and vomiting
- •Indigestion
- •Change in bowel habit or stools
- •Jaundice and itch
- •Abdominal swelling
- •Genitourinary symptoms
- •Dysuria
- •Change in urine appearance
- •Frequency and nocturia
- •Hesitancy
- •Contents
- •Loin pain
- •Incontinence
- •Menstruation
- •Discharge
- •Neurological symptoms
- •Headache
- •Dizziness and vertigo
- •Loss of consciousness
- •Visual disturbance
- •Altered hearing
- •General principles
- •Altered smell
- •Speech disturbance
- •Limb weakness, paraesthesiae and sensory loss
- •Metabolic and endocrine symptoms
- •Musculoskeletal symptoms
- •Pain
- •Weakness
- •Overview
- •The history
- •Presenting complaint (PC)
- •Visual survey
- •Position
- •Hands
- •Radial pulse
- •Blood pressure
- •Brachial and carotid artery
- •Jugular Venous Pressure
- •Face
- •Praecordium
- •Apex beat
- •Palpation
- •Auscultation
- •Summary
- •The respiratory system
- •Visual survey
- •Stiffness
- •Joint swelling
- •Disability
- •Skin symptoms
- •Rash
- •Pruritus
- •Precipitants
- •Haematological symptoms
- •Fatigue
- •Excessive bleeding or bruising
- •Recurrent infections
- •Glandular swelling
- •Conclusion of history taking
- •2 Clinical examination
- •ABCDE approach
- •Massive Blood Loss Protocol
- •General principles
- •Visual survey
- •Patient position, general behaviour and around the bed
- •Pallor
- •Cyanosis
- •Jaundice
- •Fluid status
- •Pigmentation
- •The face and body habitus
- •The hands
- •Hands
- •Nails
- •Tendons
- •Joints
- •Neuromuscular
- •Miscellaneous
- •The cardiovascular system
- •Position
- •Hands
- •Pulse
- •Blood pressure
- •Jugular venous pressure
- •Face and mouth
- •Trachea
- •Thorax
- •Inspection
- •Expansion
- •Tactile fremitus and vocal fremitus
- •Percussion
- •Auscultation
- •Summary
- •The abdomen
- •Visual survey
- •Position
- •Hands
- •Arms
- •Face and mouth
- •Neck
- •Trunk and back
- •Abdomen
- •Inspection
- •Palpation
- •Percussion
- •Auscultation
- •Concluding your examination
- •The nervous system
- •Visual survey
- •Cranial nerves
- •Cranial nerve I (olfactory nerve)
- •Cranial nerve II (optic nerve)
- •Cranial nerves III, IV and VI and eye movements
- •Cranial nerve III (oculomotor nerve)
- •Cranial nerve IV (trochlear nerve)
- •Cranial nerve VI (abducens nerve)
- •Cranial nerve V (trigeminal nerve)
- •Cranial nerve VII (facial nerve)
- •Cranial nerve VIII (vestibulocochlear nerve)
- •Cranial nerve IX (glossopharyngeal nerve)
- •Cranial nerve X (vagus nerve)
- •Cranial nerve XI (accessory nerve)
- •Cranial nerve XII (hypoglossal nerve)
- •Upper limb
- •Visual survey
- •Tone
- •Power
- •Coordination
- •Reflexes
- •Sensation
- •Lower limb
- •Visual survey
- •Tone
- •Power
- •Coordination
- •Reflexes
- •Sensation
- •Gait
- •Musculoskeletal examination
- •Visual survey
- •Look
- •Feel
- •Move
- •Assessment of disability
- •Hands
- •Skin and lymphadenopathy
- •Breast examination
- •Neck examination
- •3 Writing in the medical notes
- •General principles
- •Sample clerking
- •4 Chest pain
- •Introduction
- •History and examination findings
- •History
- •Type of chest pain
- •Onset and progression
- •Site and radiation
- •Nature of pain
- •Associated symptoms
- •Examination
- •Investigations
- •5 Shortness of breath
- •Introduction
- •History and examination findings
- •History
- •Onset
- •Severity
- •Precipitating and aggravating factors
- •Associated features
- •Other factors
- •Examination
- •Inspection
- •Palpation
- •Percussion
- •Auscultation
- •Investigations
- •Acute presentation
- •Chronic presentation
- •6 Cough and haemoptysis
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside
- •Blood tests
- •Imaging
- •Further investigations
- •7 Palpitations
- •Introduction
- •History and examination findings
- •History
- •Causes and contributing factors
- •Examination
- •Investigations
- •8 Pyrexia of unknown origin
- •Introduction
- •History and examination findings
- •Investigations
- •Bedside investigations
- •Blood tests
- •Microbiology tests
- •Further investigations
- •Differential diagnosis
- •9 Abdominal pain
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Ascertaining the underlying causes of abdomnal pain
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Further investigations
- •10 Heartburn and indigestion
- •Introduction
- •History and examination findings
- •Investigations
- •Common investigations
- •Specialized investigations
- •11 Gastrointestinal bleed
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Further investigations
- •12 Change in bowel habit
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Noninvasive
- •Invasive
- •Further investigations
- •13 Weight loss
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Blood tests
- •Imaging
- •14 Jaundice
- •Introduction
- •History and examination
- •History
- •Examination
- •Investigations
- •Haemolysis screen
- •Hepatocellular screen
- •Introduction
- •Micturition disturbances
- •History and examination findings
- •Examination
- •General appearance
- •Cardiovascular system
- •Abdominal examination
- •Neurological examination
- •Investigations
- •Urine tests
- •Blood tests
- •Imaging
- •Further investigations
- •Haematuria
- •History and examination findings
- •Initial tests
- •Imaging
- •Other investigations
- •Proteinuria
- •16 Headache and facial pain
- •Introduction
- •History and examination findings
- •History
- •Solitary acute episode
- •Progressive headache
- •Recurrent episodic headache and facial pain
- •Chronic headache and facial pain
- •Examination
- •Investigations
- •Blood tests
- •Imaging
- •Introduction
- •History and examination findings
- •Investigations
- •Imaging
- •Further investigations
- •Differential diagnosis
- •Thyroid disease
- •Hypothyroidism
- •Aetiology
- •Clinical features
- •Investigations
- •Blood tests
- •Other
- •Imaging
- •Hyperthyroidism
- •Aetiology
- •Primary hyperthyroidism
- •Clinical features
- •Investigations
- •Subacute (de Quervain) thyroiditis
- •Thyroid malignancy
- •Papillary thyroid carcinoma
- •Follicular thyroid carcinoma
- •Anaplastic carcinoma
- •Medullary thyroid carcinoma
- •Primary thyroid lymphoma
- •Further reading
- •18 Loss of consciousness
- •Introduction
- •History and examination findings
- •History
- •Before the event
- •The event itself
- •After the event
- •Risk factors
- •Examination
- •Comatose patient
- •Patient with blackouts
- •Investigations
- •19 Confusion and delirium
- •Introduction
- •History and examination findings
- •History
- •Pattern of confusion
- •Underlying causes
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Further tests
- •20 Stroke and TIA
- •Introduction
- •Causes and pathophysiology
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Further investigations
- •Management
- •Acute treatment
- •Prevention
- •21 Lumps
- •Introduction
- •History and examination findings
- •Investigations
- •Differential diagnosis
- •Localized lymphadenopathy
- •Generalized lymphadenopathy
- •Splenomegaly
- •22 Focal neurological deficits
- •Introduction
- •History and examination findings
- •History
- •Pattern of deficit
- •Onset
- •Precipitants
- •Progression
- •Evidence of cause
- •Examination
- •The anatomical site of the lesion
- •The underlying cause
- •The resultant disability
- •Investigations
- •Bedside investigations
- •Blood tests
- •Cerebrospinal fluid analysis
- •Imaging
- •Further investigations
- •23 Dizziness and vertigo
- •Introduction
- •History and examination findings
- •History
- •Onset and pattern of vertigo
- •Aural symptoms
- •Neurological symptoms
- •Examination
- •Investigations
- •24 Back pain and joint pain
- •Introduction
- •History and examination findings
- •History
- •Ask about associated features:
- •Other important points to consider include:
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Differential diagnosis
- •Joint disease
- •Back pain
- •25 Skin lesions and rash
- •Introduction
- •History and examination
- •History
- •Examination
- •Investigations
- •Differential diagnosis
- •Pigmented lesions
- •Scaly lesions
- •Vesicular lesions
- •Weepy or pustular lesions
- •Figurate erythema
- •Bullous lesions
- •Papular and nodular lesions
- •Photodermatoses
- •Maculopapular lesions
- •Ulcerated lesions
- •Petechial and purpuric lesions
- •Miscellaneous lesions
- •Introduction
- •History and examination findings
- •Investigations
- •Differential diagnosis
- •Platelet abnormality
- •Thrombocytopenia
- •Platelet dysfunction
- •Coagulation abnormality
- •Vitamin K deficiency
- •Factor deficiency
- •Acquired factor inhibitors
- •Vessel wall abnormalities
- •Hereditary
- •Acquired
- •27 Cardiovascular system
- •Coronary heart disease
- •General overview
- •Risk factors
- •Nonmodifiable risk factors
- •Family history
- •Ethnicity
- •Modifiable risk factors
- •Smoking
- •Poor nutrition
- •Hyperlipidaemia
- •Hypertension
- •Diabetes mellitus
- •Obesity
- •Pathophysiology
- •Clinical features
- •Investigations
- •Electrocardiogram
- •Exercise tolerance test
- •Echocardiography
- •CT coronary angiography
- •Nuclear imaging
- •Coronary angiography
- •Treatment
- •Lifestyle changes
- •Drug agents
- •Antiplatelet drugs
- •Nitrates
- •β-Blockers
- •Calcium channel blockers
- •Potassium channel activators
- •Angiotensin-converting enzyme inhibitors
- •Lipid-lowering drugs
- •Revascularization
- •Acute coronary syndrome
- •ST elevation myocardial infarction
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Acute management
- •Non-ST elevation myocardial infarction and unstable angina
- •General overview
- •Clinical features
- •Investigations
- •Risk scoring
- •Management
- •Acute management
- •Subsequent inpatient management of patients with acute coronary syndrome
- •Complications of myocardial infarction
- •Cardiac failure and cardiogenic shock
- •Cardiac rupture
- •Mitral regurgitation
- •Arrhythmias and conduction disturbances
- •Supraventricular arrhythmias
- •Arrhythmias
- •General overview
- •Investigations
- •Sinus tachycardia
- •Atrial fibrillation
- •Aetiology and pathophysiology
- •Complications
- •Management
- •Atrial flutter
- •Paroxysmal supraventricular tachycardia
- •Atrioventricular reentry tachycardia
- •Atrioventricular nodal reentry tachycardia
- •Management
- •Ventricular tachycardia
- •Torsades de pointes
- •Ventricular fibrillation
- •Bradycardias
- •Sinus bradycardia
- •Sick sinus syndrome
- •Heart block
- •Antiarrhythmic drugs
- •Supraventricular arrhythmias only
- •Supraventricular and ventricular arrhythmias
- •Ventricular arrhythmias
- •Heart failure
- •General overview
- •Aetiology
- •Clinical features
- •Left-sided heart failure
- •Right-sided heart failure
- •Congestive cardiac failure
- •Investigations
- •Blood tests
- •Imaging
- •Other
- •Management of acute heart failure
- •Management of chronic heart failure
- •Drug treatment
- •Angiotensin-converting enzyme inhibitors
- •β-Blockers
- •Diuretics
- •Aldosterone antagonists
- •Hydralazine in combination with a nitrate
- •Digoxin
- •Ivabradine
- •Nondrug therapy
- •Implantable cardioverter defibrillator and cardiac resynchronization therapy
- •Left ventricular assist devices
- •Transplantation
- •Hypertension
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Drug treatment
- •Angiotensin-converting enzyme inhibitors
- •Angiotensin II receptor blockers
- •Calcium channel blockers
- •Thiazide diuretics
- •β-Blockers
- •α-Adrenergic receptor blockers
- •Central acting agents
- •Vasodilators
- •Management of hypertension in pregnancy
- •Malignant (accelerated) hypertension
- •Valvular heart disease
- •General overview
- •Mitral stenosis
- •Clinical features
- •Management
- •Mitral regurgitation
- •Clinical features
- •Management
- •Mitral valve prolapse
- •Aortic stenosis
- •Clinical features
- •Management
- •Aortic regurgitation
- •Clinical features
- •Management
- •Tricuspid regurgitation
- •Pulmonary valve lesions
- •Miscellaneous conditions
- •Pericarditis and pericardial effusion
- •Clinical features
- •Management
- •Constrictive pericarditis
- •Cardiomyopathy
- •Hypertrophic obstructive cardiomyopathy
- •Dilated cardiomyopathy
- •Restrictive/infiltrative cardiomyopathy
- •Arrhythmogenic right ventricular dysplasia
- •Infective endocarditis
- •Clinical features
- •Management
- •Rheumatic fever
- •Major Jones criteria
- •Carditis (40%–50%)
- •Polyarthritis (80%)
- •Sydenham chorea (10%)
- •Erythema marginatum (5%)
- •Subcutaneous nodules (rare)
- •Management
- •Atrial myxomata
- •Congenital heart disease in adults
- •Acyanotic conditions
- •Atrial septal defect
- •Ventricular septal defect
- •Patent ductus arteriosus
- •Aortic coarctation
- •Aortic and pulmonary stenosis
- •Cyanotic conditions
- •Tetralogy of Fallot
- •Further reading
- •28 Respiratory system
- •Respiratory failure
- •General overview
- •Type I respiratory failure
- •Causes
- •Management
- •Type II respiratory failure
- •Causes
- •Management
- •Asthma
- •General overview
- •Aetiology
- •Pathophysiology
- •Clinical features
- •Investigations
- •Management
- •Emergency management
- •Long-term management
- •Chronic obstructive pulmonary disease
- •General overview
- •Aetiology
- •Cigarette smoking
- •α1-Antitrypsin deficiency
- •Occupation
- •Pathophysiology
- •Clinical features
- •Investigations
- •Management
- •Short-term management
- •Long-term management
- •Bronchiectasis
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Pneumonia
- •General overview
- •Aetiology
- •Community-acquired pneumonia
- •Atypical pneumonia
- •Hospital-acquired pneumonia (nosocomial)
- •Aspiration pneumonia
- •Opportunistic pneumonia
- •Clinical features
- •Typical
- •Atypical
- •Investigations
- •Bedside
- •Imaging
- •Other tests
- •CURB65 score
- •Management
- •Pulmonary embolism
- •Clinical features
- •Investigations
- •Management
- •Lung cancer
- •General overview
- •Aetiology
- •Pathology
- •Clinical features
- •Paraneoplastic syndrome
- •Investigations
- •Tumour, Node, Metastasis (TNM) staging
- •Management
- •Tuberculosis
- •General overview
- •Pathogenesis
- •Pulmonary tuberculosis
- •Extrapulmonary tuberculosis
- •Clinical features
- •Systemic
- •Pulmonary
- •Extrapulmonary
- •Investigations
- •Management
- •Pneumothorax
- •General overview
- •Clinical features
- •Management
- •Pleural effusion
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Interstitial lung disease
- •General overview
- •Aetiology
- •Known cause:
- •Unknown cause:
- •Clinical features
- •Investigations
- •Management
- •Idiopathic pulmonary fibrosis
- •Sarcoidosis
- •Occupational lung disease
- •Aspergillus and the lung
- •Hypoventilation syndromes and sleep-related respiratory disorders
- •General overview
- •Obstructive sleep apnoea syndrome
- •Obesity hypoventilation syndrome
- •Congenital hypoventilation syndrome
- •Acute respiratory distress syndrome
- •General overview
- •Management
- •Cystic fibrosis
- •General overview
- •Clinical features
- •Management
- •Further Reading
- •Upper gastrointestinal tract
- •Oesophageal disorders
- •Gastro-oesophageal reflux disease
- •Clinical features
- •Investigations
- •Management
- •Complications
- •Hiatus hernia
- •Sliding hiatus hernia
- •Rolling (or paraoesophageal) hiatus hernia
- •Barrett oesophagus
- •Eosinophilic oesophagitis
- •Oesophageal motility disorders
- •Achalasia
- •Oesophageal cancer
- •Clinical features
- •Investigations
- •Management
- •Gastroduodenal disorders
- •Gastroduodenitis and peptic ulcer disease
- •Clinical features
- •Investigations
- •Management
- •Upper gastrointestinal tract haemorrhage
- •Management
- •Gastric cancer
- •Clinical features
- •Management
- •Gastrointestinal stromal tumour
- •Small bowel disorders
- •Malabsorption
- •Coeliac disease
- •Bacterial overgrowth
- •Tropical sprue
- •Whipple disease
- •Neuroendocrine tumours of the bowel
- •Carcinoid tumours
- •Gastrinoma
- •Insulinomas
- •VIPomas
- •Glucagonomas
- •Lower gastrointestinal tract
- •Colorectal disorders
- •Colorectal neoplasia
- •Benign disease
- •Colorectal cancer
- •Screening
- •Diverticular disease
- •Clinical features
- •Investigations
- •Management
- •Clostridium difficile and pseudomembranous colitis
- •Lower gastrointestinal tract bleeding
- •Ischaemic colitis
- •Microscopic colitis
- •Irritable bowel syndrome
- •Clinical features
- •Investigations
- •Management
- •Nonulcer dyspepsia
- •Inflammatory bowel disease
- •General overview
- •Ulcerative colitis
- •Crohn disease
- •Hepatobiliary system
- •Gallbladder disorders
- •Gallstones and biliary colic
- •Clinical features
- •Investigations
- •Management
- •Acute cholecystitis
- •Clinical features
- •Investigations
- •Management
- •Recurrent cholecystitis
- •Biliary tract cancer
- •Cholangiocarcinoma
- •Gallbladder cancer
- •Cancer of the ampulla of Vater
- •Pancreatic disorders
- •Acute pancreatitis
- •Clinical features
- •Investigations
- •Management
- •Chronic pancreatitis
- •Investigations
- •Management
- •Pancreatic cancer
- •Clinical features
- •Investigations
- •Management
- •Liver disorders
- •Chronic liver disease
- •Established chronic liver disease
- •Hepatitis
- •Acute hepatitis
- •Acute viral hepatitis
- •Hepatitis A
- •Epidemiology
- •Hepatitis B
- •Hepatitis C
- •Investigations
- •Management
- •Autoimmune hepatitis
- •Alcoholic liver disease
- •Pathology
- •Clinical features
- •Investigations
- •Prognosis
- •Nonalcoholic steatohepatitis
- •Haemochromatosis
- •Investigations
- •Management
- •Primary biliary cholangitis
- •Primary sclerosing cholangitis
- •Wilson disease (hepatocellular degeneration)
- •Clinical features
- •Investigations
- •Management
- •Hepatic tumours
- •Benign tumours
- •Malignant tumours
- •Miscellaneous conditions
- •α1-Antitrypsin deficiency
- •Liver abscess
- •Budd–Chiari syndrome
- •Further reading
- •Haematuria and proteinuria
- •Proteinuria
- •Benign proteinuria
- •Pathological proteinuria
- •Overflow proteinuria
- •Clinical Features
- •Investigations
- •Urine
- •Blood tests
- •Imaging
- •Histological diagnosis
- •Acute kidney injury
- •Aetiology
- •Clinical features
- •Investigations
- •Urine
- •Blood tests
- •Other tests
- •Management
- •Hyperkalaemia
- •Acidosis
- •Pulmonary oedema
- •Renal replacement therapies
- •Supportive management
- •Summary
- •Chronic kidney disease
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Prevention of decline in renal function
- •Prevention of complications
- •Cardiovascular
- •Renal osteodystrophy
- •Acidosis
- •Anaemia
- •Hyperkalaemia
- •End-stage renal failure
- •Glomerular disease
- •Clinical features
- •Nephritic syndrome
- •Nephrotic syndrome
- •History
- •Investigations
- •Urine
- •Blood tests
- •Imaging
- •Renal biopsy
- •Management
- •Important primary and secondary glomerular diseases
- •Rapidly progressive glomerulonephritis
- •Antiglomerular basement membrane disease
- •IgA nephropathy
- •Lupus nephritis
- •Minimal change nephropathy
- •Focal segmental glomerulosclerosis
- •Membranous glomerulonephritis
- •Membranoproliferative glomerulonephritis
- •Poststreptococcal glomerulonephritis
- •Urinary tract infections
- •Lower urinary tract infections
- •Upper urinary tract infections
- •Clinical features
- •Investigations
- •Management
- •Renal calculi
- •General overview
- •Clinical features
- •Management
- •Urinary tract malignancies
- •Renal cell carcinoma
- •Transitional cell carcinoma
- •Prostatic carcinoma
- •Testicular cancer
- •Miscellaneous conditions
- •Adult polycystic kidney disease
- •Hepatorenal syndrome
- •Thrombotic microangiopathies
- •Sexually transmitted diseases
- •Chlamydia
- •Gonorrhoea
- •Syphilis
- •Further reading
- •Sodium and water balance
- •Hyponatraemia
- •Investigations
- •Hypernatraemia
- •Focal onset seizures
- •Normal awareness
- •Impaired awareness
- •Focal evolving to bilateral convulsive seizures
- •Generalized onset seizures
- •Tonic–clonic (grand mal) seizures
- •Absence attacks (petit mal)
- •Myoclonic seizure
- •Atonic or akinetic epilepsy
- •Aetiology
- •Hypokalaemia
- •Investigations
- •Management
- •Hyperkalaemia
- •Investigations
- •Management
- •Calcium balance
- •Hypocalcaemia
- •Hypercalcaemia
- •Investigations
- •32 Nervous system
- •Cerebrovascular disease
- •Stroke and TIA
- •Intracerebral haemorrhage
- •Subarachnoid haemorrhage
- •Clinical features
- •Investigations
- •Management
- •Subdural haematoma
- •Extradural haematoma
- •Headache
- •Migraine
- •General overview
- •Clinical features
- •Management
- •Cluster headache
- •Tension-type headache
- •Idiopathic intracranial hypertension
- •Trigeminal neuralgia
- •Persistent idiopathic facial pain (atypical facial pain)
- •Dementia
- •Epilepsy
- •General overview
- •Classification
- •Investigations
- •Bedside
- •Imaging
- •Electroencephalogram
- •Management
- •Drug treatment
- •First-line drugs
- •Second-line drugs
- •Withdrawing drugs
- •Other treatment
- •Status epilepticus
- •Pregnancy and epilepsy
- •Driving and work and epilepsy
- •Sudden unexpected death in epilepsy
- •Intracranial tumours
- •General overview
- •Clinical features
- •Raised intracranial pressure
- •Investigations
- •Management
- •Movement disorders
- •Parkinsonism
- •Clinical features
- •Tremor
- •Rigidity
- •Bradykinesia
- •Other features
- •Management
- •Drug therapy
- •Other therapy
- •Tremor
- •Essential tremor
- •Cerebellar tremor
- •Huntington Disease
- •Sydenham chorea
- •Other movement disorders
- •Multiple sclerosis
- •General overview
- •Pathogenesis
- •Clinical features
- •Optic neuritis
- •Diplopia
- •Sensory symptoms
- •Motor weakness
- •Cerebellar signs
- •Other manifestations
- •Investigations
- •Management
- •Central nervous system infection
- •Meningitis
- •General overview
- •Causative organisms
- •Clinical features
- •Meningism
- •Sepsis
- •Raised intracranial pressure
- •Investigations
- •Management
- •Encephalitis
- •Central nervous system abscess
- •Spinal cord infection
- •Spinal cord disorders
- •Spinal cord compression
- •Subacute combined degeneration of the cord
- •Syringomyelia and syringobulbia
- •Peripheral nervous system disorders
- •Peripheral neuropathy
- •Guillain–Barré syndrome
- •Clinical features
- •Investigations
- •Management
- •Entrapment/compression neuropathies
- •Neuromuscular disorders
- •Muscle disorders
- •Myotonic dystrophy (myotonia dystrophica)
- •Muscular dystrophy
- •Duchenne and Becker muscular dystrophy (pseudohypertrophic)
- •Facioscapulohumeral dystrophy (Landouzy–Dejerine syndrome)
- •Limb girdle dystrophy
- •Neuromuscular junction disorders
- •Myasthenia gravis
- •Clinical features
- •Investigations
- •Management
- •Lambert–Eaton myasthenic syndrome
- •Miscellaneous disorders
- •Motor neurone disease
- •Management
- •Horner syndrome
- •Bulbar and pseudobulbar palsy
- •Bell palsy
- •Further reading
- •Diabetes mellitus
- •Aetiology and Pathophysiology
- •Clinical features
- •Macrovascular disease
- •Microvascular disease
- •Diabetic retinopathy
- •Diabetic nephropathy
- •Diabetic neuropathy
- •Diabetic feet
- •Skin
- •Infections
- •Management
- •Diet and lifestyle
- •Oral hypoglycaemic agents
- •Biguanides
- •Sulphonylureas
- •Meglitinides; rapid-acting insulin secretagogues
- •Thiazolidinediones
- •Dipeptidyl peptidase 4 inhibitors
- •Glucagon-like peptide 1 agonists
- •Acarbose
- •Insulin
- •Diabetes and surgery
- •Diabetic emergencies
- •Hypoglycaemia
- •Diabetic ketoacidosis
- •Hyperosmolar hyperglycaemic state
- •Obesity and metabolic syndrome
- •Lipid disorders
- •Aetiology and pathophysiology
- •Primary hyperlipidaemia
- •Secondary hyperlipidaemia
- •Investigations
- •Management
- •Primary prevention
- •Secondary prevention
- •Drugs
- •Thyroid disease
- •Hypothyroidism
- •Management
- •Hyperthyroidism
- •Management
- •Antithyroid drugs
- •Radioiodine
- •Subtotal thyroidectomy
- •Thyroid emergencies
- •Thyrotoxic crisis (‘thyroid storm’)
- •Myxoedema coma
- •Parathyroid disease
- •Hypoparathyroidism
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Hyperparathyroidism
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Pituitary disorders
- •Hypopituitarism
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Pituitary tumours
- •Clinical features
- •Investigations
- •Management
- •Acromegaly
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Surgery
- •Radiotherapy
- •Medical therapies
- •Prognosis
- •Prolactin disorders
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Diabetes insipidus
- •Cranial diabetes insipidus
- •Nephrogenic diabetes insipidus
- •Management
- •Adrenal disorders
- •Cushing syndrome
- •Clinical features
- •Investigations
- •Management
- •Cushing disease
- •Adrenocortical tumours
- •Ectopic adrenocorticotrophic hormone syndrome
- •Addison disease
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Conn syndrome (primary hyperaldosteronism)
- •Clinical features
- •Investigations
- •Management
- •Phaeochromocytoma
- •Clinical features
- •Investigations
- •Management
- •Hypothalamus–pituitary–adrenal axis
- •Dynamic tests for cortisol excess
- •Tests for cortisol deficiency
- •Pituitary function tests
- •Miscellaneous endocrine conditions
- •Multiple endocrine neoplasia
- •Autoimmune polyendocrine syndrome
- •Congenital adrenal hyperplasia
- •Metabolic bone disease
- •Osteoporosis
- •Aetiology
- •Primary osteoporosis
- •Secondary osteoporosis
- •Clinical features
- •Investigations
- •Management
- •General principles
- •Drugs
- •Paget disease
- •Clinical features
- •Investigations
- •Management
- •Bisphosphonates
- •Calcitonin
- •Surgery
- •Osteomalacia
- •Aetiology
- •Clinical features
- •Investigations
- •Biochemistry
- •Imaging
- •Management
- •Renal osteodystrophy
- •Management
- •Further reading
- •34 Musculoskeletal system
- •Osteoarthritis
- •Pathology
- •Clinical features
- •Management
- •Rheumatoid arthritis
- •Pathology
- •Clinical features
- •Management
- •Spondyloarthropathies
- •Ankylosing spondylitis
- •Pathology
- •Clinical features
- •Management
- •Reactive arthritis
- •Pathology
- •Clinical features
- •Management
- •Psoriatic arthritis
- •Enteropathic arthropathies
- •Crystal arthropathy
- •Gout
- •Pathology
- •Clinical features
- •Management
- •Pseudogout
- •Connective tissue disorders
- •Systemic lupus erythematosus
- •Pathology
- •Clinical features
- •Treatment
- •Systemic sclerosis
- •Pathology
- •Clinical features
- •Management
- •Polymyositis and dermatomyositis
- •Pathology
- •Clinical features
- •Management
- •Sjögren syndrome
- •Vasculitis
- •General overview
- •Eosinophilic granulomatosis with polyangiitis
- •Granulomatosis with polyangiitis
- •Henoch–Schönlein purpura
- •Kawasaki disease
- •Microscopic polyangiitis
- •Polyarteritis nodosa
- •Behçet disease
- •Polymyalgia rheumatica and giant cell arteritis
- •Polymyalgia rheumatica
- •Giant cell arteritis
- •Antiphospholipid syndrome
- •35 Skin disease
- •Skin manifestations of systemic disease
- •Diabetes mellitus
- •Inflammatory bowel disease
- •Coeliac disease
- •Hyperthyroidism
- •Malignant disease
- •Sarcoidosis
- •Rheumatic fever
- •Neurofibromatosis
- •Lyme disease (borreliosis)
- •Hyperlipidaemia
- •Skin disease
- •Psoriasis
- •Clinical features
- •Management
- •Eczema/dermatitis
- •Clinical features
- •Management
- •Acne vulgaris
- •Actinic keratosis
- •Seborrhoeic keratosis
- •Herpes simplex
- •Herpes (varicella) zoster
- •Lichen planus
- •Erythema multiforme
- •Stevens–Johnson syndrome and toxic epidermal necrolysis
- •Pemphigus vulgaris and bullous pemphigoid
- •Erythema nodosum
- •Vitiligo
- •Pyoderma gangrenosum
- •Neoplastic disease
- •Basal cell carcinoma
- •Squamous cell carcinoma
- •Malignant melanoma
- •Infections
- •Impetigo
- •Cellulitis
- •Necrotizing fasciitis
- •36 Haematological disorders
- •Anaemia
- •Diagnosis
- •Management
- •Iron replacement
- •Vitamin B12 and folate replacement
- •Blood transfusion
- •Splenectomy
- •Erythropoietin
- •Causes of anaemia
- •Anaemia of chronic disease
- •Clinical features
- •Management
- •Haemolytic anaemia
- •Clinical features
- •Management
- •Sickle cell anaemia
- •Clinical features
- •Management
- •Thalassaemia
- •Clinical features
- •Management
- •Aplastic anaemia
- •Clinical features
- •Management
- •Leukaemia
- •Acute lymphoblastic leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Acute myeloid leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Chronic lymphocytic leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Chronic myeloid leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Multiple myeloma
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Lymphoma
- •Hodgkin disease
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Non-Hodgkin lymphoma
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Myelodysplastic syndromes
- •Classification
- •Clinical features
- •Management
- •Myeloproliferative disease
- •Polycythaemia vera
- •Essential thrombocythaemia
- •Primary myelofibrosis
- •Bleeding disorders
- •Haemophilia A
- •Haemophilia B (Christmas disease)
- •Von Willebrand disease
- •Immune thrombocytopenia
- •Disseminated intravascular coagulation
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Thrombotic disorders and thromboembolism
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Thrombotic thrombocytopenic purpura
- •Haemolytic uraemic syndrome
- •37 Infectious diseases
- •General overview
- •HIV and AIDS
- •Epidemiology and aetiology
- •Pathology
- •Clinical features
- •Primary HIV infection
- •Clinical stage 1
- •Clinical stage 2
- •Clinical stages 3 and 4
- •Treatment and prognosis
- •Prevention
- •Malaria
- •Epidemiology and aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Prevention
- •Diarrhoeal disease
- •Drug-resistant bacteria
- •Other resistant bacteria
- •38 Drug overdose and abuse
- •General overview
- •Common presentation, investigations and management
- •History
- •Examination
- •How ill is the patient?
- •Is there any evidence to suggest an underlying cause?
- •Have any complications occurred?
- •Investigations
- •Management
- •Supportive care
- •Preventing absorption
- •Increase elimination of drug
- •Specific antidotes
- •Psychiatric and social assessment
- •Paracetamol overdose
- •Illegal drugs
- •Alcohol misuse and withdrawal
- •Alcohol withdrawal
- •Wernicke encephalopathy/Korsakoff psychosis
- •Long-term treatment
- •Further reading
- •Self-Assessment
- •SBA answers
- •EMQ answers
- •Index

Drug overdose and abuse
• Activated charcoal is ineffective in the case of iron,
lithium, alcohol and cyanide poisoning or overdose.
• Whole bowel irrigation is not routinely recommended
but can be considered in iron overdose or in the case of
enteric-coated drugs.
Removal of the drug from the gastrointestinal tract is
controversial. The potential benefits of reducing drug absorption may be outweighed by the hazards of the methods used (e.g. aspiration of stomach contents) or may
cause a paradoxical increase in drug absorption. It should
be considered only for people who present early, are fully
conscious with a protected airway and are at risk of significant harm because of the poisoning. Induced emesis is not
recommended. Gastric lavage should be undertaken only
within 1 hour of ingestion.
Increase elimination of drug
Elimination of drugs can be increased by urinary alkalinization or through extracorporeal circuits, including haemodialysis, or haemoperfusion. Urinary alkalinization increases
renal excretion of mildly acidic drugs. It is used in severe
salicylate, phenobarbital and amphetamine overdose. A
high urinary output is required, and fluid balance, electrolyte levels and acid–base status should be monitored very
carefully.
Extracorporeal circuits are used when the clinical condition fails to respond to maximum supportive care, or when
the serum level of the drug is known to result in significant
risk of organ failure and the rate of extracorporeal clearance exceeds that of endogenous hepatic or renal clearance.
Haemodialysis is especially useful for overdose of salicylate,
lithium, alcohol and polyethylene glycol. With haemoperfusion, blood passes through a cartridge containing a sorbent,
and can enable the removal of protein-bound drugs (e.g.
phenytoin and tricyclic antidepressants).
PARACETAMOL OVERDOSE
Paracetamol overdose is the most common agent of intentional self-harm, and the most common cause of acute
liver failure. Overdose, even in small amounts, can cause
fatal liver damage. To prevent this, paracetamol should be
suspected as a component of all overdoses. Plasma concentrations should be measured and compared against a nomogram (paracetamol treatment graph); see Fig.38.1. Patients
with plasma concentrations above the treatment line are at
risk of liver damage and require antidote treatment with
N-acetylcysteine. It is important to know the time the
paracetamol was consumed, whether the intake of the drug
was staggered and whether it was a mixed overdose. Certain
individuals are at higher risk of paracetamol-induced liver
disease, including patients who are malnourished, have
preexisting liver disease, chronic alcoholism or HIV, or are
taking liver enzyme inducing drugs (e.g. phenytoin, carbamazepine). Treatment includes giving activated charcoal if
the individual presents within 1 hour. Paracetamol levels are
measured 4 hours after ingestion; if serum levels are above
the treatment line, infusion of N-acetylcysteine is commenced. This infusion lasts around 24 hours. In the context
of paracetamol overdose with a delayed presentation (>8
hours), N-acetylcysteine infusion should be started immediately until a drug level is available. Following the overdose
the patient should be closely monitored, with careful attention to liver function test levels, glucose level and international normalized ratio (INR). A rising INR >2 at 24 hours
should prompt discussion with a specialist liver centre. In
the context of a staggered overdose, patients presenting
with evidence of severe toxicity or fulminant hepatic failure,
N-acetylcysteine infusion should be started immediately.
Specific antidotes
Advice for the management of overdose of any drug or ingestion of any poison can be obtained 24 hours a day from
several poisons information centres run by the National
Poisons Information Service. Each emergency department
and hospital switchboard will have a list of national numbers, as well as access to the National Poisons Information
Service online database and TOXBASE, which provides a
vast amount of detailed information.
Table38.1 summarizes the features and management of
overdose of some of the more common drugs.
Psychiatric and social assessment
Once the acute event and medical management is completed, the patient's psychiatric state, ongoing risk of
suicide and social circumstances should be assessed, however trivial the overdose may have appeared. Where appropriate, psychiatrists and social care workers should be
involved.
388
ILLEGAL DRUGS
Because of their nature, there is often less information
available on the treatment of adverse effects associated with
illicit drugs. In addition, new drugs emerge and quickly become widely used. TOXBASE is very useful in this regard.
Table38.2 details some of the features seen with com-
monly used illegal drugs.
ALCOHOL MISUSE AND WITHDRAWAL
Alcohol is widely used throughout the world. The lifetime
incidence of alcohol dependence in the United Kingdom
is 4%, and more than 24% of the English population consumes alcohol in a way that is potentially, or actually, harmful to their well-being. Alcohol misuse is a huge problem

Alcohol misuse and withdrawal
120
0.8
Time (hours)
Plasma-paracetamol concentration (mmol/litre)
Plasma-paracetamol concentration (mg/litre)
3838
110
100
90
80
70
60
50
40
30
20
10
Fig.38.1 Paracetamol nomogram. (Reprinted with permission from the Royal College of Emergency Guidance. https://
www.rcem.ac.uk/docs/Paracetamol%20Overdose/Annex%201_The%20treatment%20nomogram%20and%20
Annex%202_Technical_info.pdf.)
in terms of morbidity, mortality and healthcare costs. The
CAGE questionnaire is commonly used as a screening tool
for alcohol problems.
Treatment line
0
0246810
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
12 14 16 18 20 22 24
• Systemic complications; for example:
• Gastrointestinal: gastritis, oesophagitis, varices,
alcoholic liver disease (see Chapter 29).
• Cardiovascular: arrhythmia, cardiomyopathy,
COMMUNICATION
The CAGE questionnaire:
• Have you ever felt you needed to cut down on
your drinking?
• Has anyone ever annoyed you by criticizing your
drinking?
• Have you ever felt guilty about your drinking?
• Have you ever needed a drink in the morning –
an ‘eye-opener’ – to make yourself feel better?
A positive answer to any of these questions is
indicative of possible alcohol dependence.
hypertension.
• Respiratory: increased incidence of pneumonia and TB
due to reduced clearance of pathogens.
• Neurological: cortical atrophy, cerebellar degeneration,
peripheral neuropathy, Wernicke encephalopathy/
Korsakoff syndrome.
• Endocrine: gynaecomastia, testicular atrophy,
osteoporosis.
• Increased risk of cancer, particularly oesophageal and
head and neck cancers.
Alcohol withdrawal
Patients experiencing alcohol withdrawal are difficult to
treat and, despite initial willingness, often self-discharge.
The standard treatment is a course of benzodiazepines, usu-
Alcohol misuse can result in acute intoxication, problems
associated with alcohol withdrawal and systemic complications of alcohol use:
• Acute intoxication: alcohol causes euphoria and
reduced inhibition. In greater quantities it may cause
reduced conscious level, respiratory depression, atrial
fibrillation, hypoglycaemia and hypotension.
• Alcohol withdrawal: tremor, sweating, tachycardia,
irritability, agitation, hallucinations, delusions, seizures.
Symptoms usually start within 24 hours of the last
alcohol intake.
ally chlordiazepoxide, which is slowly reduced over several
days; most hospitals have a dosing protocol. The Clinical
Institute Withdrawal Assessment for Alcohol (CWIA) scale
is used to quantify the severity of the alcohol withdrawal
syndrome and to guide the patient’s chlordiazepoxide requirement. Delirium tremens, or delirium- associated alcohol withdrawal, is a severe form of withdrawal which
occurs in approximately 5% of patients who undergo ethanol withdrawal. Delirium tremens is associated with a
high risk of morbidity and death. The onset is usually between 2 and 5days following cessation of alcohol intake.
389

Drug overdose and abuse
Features include severe tremor, clouding of consciousness,
delusions, tachycardia, agitation, fever and severe hallucinations (mainly visual but can be tactile or auditory and
often cause extreme fear). Delirium tremens is treated by
calming and reorientation of the patient, and use of oral
benzodiazepines, lorazepam being first line. If seizures occur, these should be treated with intravenous benzodiazepines. Occasionally antipsychotics such as haloperidol are
required for severe withdrawal psychosis.
RED FLAG
If seizures occur in a patient withdrawing from
alcohol, consider if there is another intracranial
disorder. These patients are at higher risk of
subdural haemorrhages.
Wernicke encephalopathy/ Korsakoff psychosis
Wernicke encephalopathy is an acute life-threatening neurological syndrome consisting of confusion, ophthalmoplegia and ataxia. The most common cause is thiamine
deficiency associated with alcoholism. If not treated, it can
lead to irreversible amnesia: Wernicke–Korsakoff psychosis. This is a late neuropsychiatric syndrome characterized
by memory loss and confabulation.
Heavy alcohol consumption can affect absorption of thiamine (vitamin B1), and people with alcoholism can be at
risk of this condition despite having a normal balanced diet.
To avoid this thiamine in the form of Pabrinex (IV vitamin
B with ascorbic acid) should be administered intravenously
for a minimum of 48 hours, and for 1week in the case of
Wernicke encephalopathy, followed by oral administration
of thiamine and vitamin B replacement.
RED FLAG
If thiamine deficiency is suspected, thiamine
should be replaced before glucose is replaced.
Prolonged carbohydrate administration without
thiamine supplementation has been reported to
precipitate Wernicke encephalopathy.
Long-term treatment
Regular psychosocial input is essential. This may include
counselling, cognitive behavioural therapy and self-help
groups (e.g. Alcoholics Anonymous). Once withdrawal has
been completed, there are three currently recommended
pharmacological aids which can be considered along with
individual psychological intervention:
• Naltrexone: a partial agonist at opioid receptors. It
reduces the pleasurable effects from alcohol; it reduces
cravings, and is associated with a lower relapse rate. It
is useful in patients who are binge drinkers.
• Acamprosate (calcium acetyl homotaurinate): This
blocks γ-aminobutyric acid receptors and reduces
N-methyl-d-aspartate excitation. It reduces cravings
and does not interact with alcohol. It can be given after
detoxification to maintain stabilization.
• Nalmefene: This is used in individuals with
alcohol dependence without physical withdrawal
symptoms and who do not require immediate
detoxification.
Chapter Summary
• In a patient with an overdose it is important to establish the risk of the overdose. What
drugs were taken? Was it a mixed overdose? How many tablets were taken and at what
time? Was it staggered?
• Establish whether the intent was suicide or a call for help. Planned suicide attempts with
no intention to be found represent the highest risk. All patients should be seen by a
psychiatrist following an overdose.
• Always consider whether an overdose has been taken in an unconscious patient. Assess
the patient with a systematic ABC approach. Assess the conscious level and consider if
the patient can protect their own airway.
• Paracetamol and salicylate levels should be measured in all patients suspected of taking
a drug overdose.
• Specific drug overdoses have specific treatments. TOXBASE is a very useful guide.
• Alcohol misuse is common. Screen all patients for alcohol dependence and consider the
need for oral benzodiazepines to prevent alcohol withdrawal in hospitalized patients.
Have a low threshold to give thiamine replacement to reduce the risk of the patient
developing a Wernicke–Korsakoff syndrome.
390

Further reading
3838
FURTHER READING
Battista, E., 2012. Crash Course: Pharmacology, fourth ed. Mosby,
Edinburgh.
National Institute for Health and Clinical Excellence, 2004. Self-
harm. Clinical guideline CG16. Available online at: http://www.
nice.org.uk/CG16.
National Institute for Health and Clinical Excellence, 2011. Alcohol
dependence and harmful alcohol use. Clinical guideline CG115.
Available online at: http://www.nice.org.uk/CG115.
Vale, J.A., Bradberry, S.M., Bateman, D.N., 2010. Poisoning by
drugs and chemicals. In: Warrell, D.A., Cox, T.M., Firth, J.D.
(Eds.), Oxford Textbook of Medicine. fifth ed. Oxford University
Press, Oxford, pp. 873–922.
391

This page intentionally left blank

SELF-ASSESSMENT
Single best answer (SBA) questions � � � � � � � � � � � � � � � � 395
Extended-matching questions (EMQs) � � � � � � � � � � � � � � 409
SBA answers � � � � � � � � � � � � � � � � � � � � � � � � � � � � 421
EMQ answers � � � � � � � � � � � � � � � � � � � � � � � � � � � � 431

This page intentionally left blank

Single best answer (SBA)
questions
Chapter28 Respiratory system
1. A 51-year-old builder was involved in a high-speed
road traffic incident. Basic first aid was provided
at the scene according to advanced trauma life
support principles and he was subsequently
transferred to hospital. Whilst the builder was being
formally assessed, one of the FY2 doctors in the
emergency department noticed the patient's oxygen
saturations had dropped to 85%. He is concerned
the patient may have a tension pneumothorax.
Which one of the following is not a feature of a
tension pneumothorax?
A. The trachea is deviated towards the affected
side.
B. Increased percussion note over the
pneumothorax.
C. Asymmetrical expansion of the chest.
D. Absent/diminished breath sounds over the
pneumothorax.
E. A raised jugular venous pressure.
2. A 51-year-old Pilates instructor experienced a
bimalleolar fracture of her ankle which required open
reduction and internal fixation. The operation was
a success, and she was discharged with a 3-week
course of low-molecular-weight heparin (LMWH).
Four weeks after the operation she developed
progressive shortness of breath and a dry cough.
She attended the emergency department, where
a CT pulmonary angiogram revealed large bilateral
pulmonary embolisms (PEs). Which one of the
following statements would be correct regarding
pulmonary embolus?
A. The S1Q3T3 pattern is the most common EKG
abnormality.
B. This case is unusual since haemoptysis is the
most common symptom.
C. It is rarely associated with undiagnosed
malignancy.
D. One of the earliest signs is a resting tachycardia.
E. It requires 1year of warfarin therapy.
3. A 17-year-old girl is admitted to hospital with a
wheeze and severe dyspnoea. Which one of the
following statements is true with regard to the
assessment and management of an acute asthma
attack?
A. The peak flow measure is unhelpful.
B. A normal Paco2 level is reassuring.
C. Intravenously administered magnesium may be
indicated.
D. Death is extremely rare.
E. Intravenous bronchodilator therapy is much
better than nebulized therapy.
4. A 67-year-old gardener presents to his general
practitioner with a 3-day history of productive cough,
fevers and anorexia. On examination the patient
has coarse crackles at the right base with bronchial
breathing. The GP suspects this is pneumonia and
refers the patient to be seen in hospital for a CXR
and blood cultures. Which one of the following does
not score a point in the severity assessment for
community-acquired pneumonia?
A. Blood urea level greater than 7 mmol/L.
B. Systolic blood pressure greater than 90 mmHg.
C. Respiratory rate greater than 30 per minute.
D. Confusion.
E. Age more than 65years.
5. A 72-year-old retired car mechanic presents
with a 6-month history of weight loss, cough
and occasional haemoptysis. A CXR reveals a
mass in the right hemithorax with associated
hilar shadowing. A CT scan is performed, and
subsequent bronchoscopy and biopsy makes the
diagnosis of squamous cell carcinoma of
the lung. Which one of the following statements
is true regarding squamous cell carcinoma of
the lung?
A. It is associated with the syndrome of
inappropriate antidiuretic hormone secretion.
B. It is associated with hypercalcaemia.
C. It is the most common cause of Eaton–Lambert
myasthenic syndrome.
D. Chemotherapy is the mainstay of treatment.
E. It rarely metastasizes to bone.
6. A 60-year-old man presents with a 3-month history
of worsening shortness of breath and a dry cough.
He has never smoked. A CXR is ordered and shows
diffuse peripheral infiltrate opacifications. Which
of these drugs is most likely to be associated with
interstitial lung disease?
A. Amiodarone.
B. Amoxicillin.
C. Doxycycline.
D. Enalapril.
E. Sotalol.
395

Single best answer (SBA) questions
7. A 46-year-old woman with a known diagnosis of
sarcoidosis presents to the emergency department
with worsening dyspnoea. A chest X-ray (CXR) is
performed, and she is subsequently reported as
having stage 3 pulmonary sarcoidosis. Which one of
the following is the CXR most likely to show?
A. A pleural effusion.
B. Bilateral hilar lymphadenopathy.
C. Bilateral hilar lymphadenopathy with
reticulonodular shadowing.
D. Fibrocystic sarcoidosis typically with upward hilar
retraction, cystic and bullous change.
E. Bilateral pulmonary infiltrates.
8. A 19-year-old student is brought by ambulance to
the emergency department with severe dyspnoea.
His peak flow is 100 L/min (normally 650 L/min). His
respiratory rate is 40 per minute, and auscultation of
his chest reveals barely audible breath sounds. His
mother tells you that he had been hyperventilating
for approximately 30 minutes before admission.
What would you expect the arterial blood gas result
to be?
A. pH 7.29, Paco2 6.3 kPa, Pao2 9.2 kPa,
bicarbonate 45 mmol/L.
B. pH 7.51, Paco2 7.9 kPa, Pao2 9.6 kPa,
bicarbonate 37 mmol/L.
C. pH 7.39, Paco2 5.3 kPa, Pao2 7.1 kPa,
bicarbonate 30 mmol/L.
D. pH 7.51, Paco2 2.0 kPa, Pao2 9.6 kPa,
bicarbonate 14 mmol/L.
E. pH 7.57, Paco2 3.2 kPa, Pao2 10.2 kPa,
bicarbonate 27 mmol/L.
9. A 56-year-old publican is admitted to the emergency
department with dyspnoea. Whilst he is waiting to
be seen by the doctor, the nurse administers oxygen
through a nasal cannula at 2 L/min as his oxygen
saturations were 89%. Which one of the following
most accurately reflects the fraction of oxygen
inspired (Fio2)?
A. 98%.
B. 50%.
C. 35%.
D. 28%.
E. 24%.
10. A 65-year-old man presents with a 1-month history
of shortness of breath and pleuritic chest pain. He
also reported a 6 kg weight loss in the past few
months. He has a medical history of hypertension.
He used to be a textile factory worker. On the basis
of the history, which statement is true regarding the
most likely diagnosis?
A. The patient has a tumour of the lung
parenchyma.
B. The condition usually accompanies pulmonary
asbestosis.
C. Diagnosis is achieved by observing pleural
plaques on CXR or CT.
D. The condition has a good prognosis.
E. Diagnosis may result in compensation for the
patient and/or family.
11. A 45-year-old originally from sub-Saharan Africa
presents to the emergency department with a
history of progressively worsening shortness of
breath. On further questioning he admits to having
a cough productive of sputum with occasional
haemoptysis and night sweats. Amongst other
tests a sputum sample is sent for culture, including
AAFB. This comes back positive, and tuberculosis
(TB) is diagnosed. What is the appropriate drug
treatment?
A. Six months of combination therapy: rifampicin,
isoniazid, pyrazinamide and ethambutol
for 4months followed by isoniazid and
pyrazinamide alone for 2months.
B. Twelve months of combination therapy:
rifampicin, isoniazid, pyrazinamide and
ethambutol for 4months followed by rifampicin
and pyrazinamide alone for 2months.
C. Six months of combination therapy: rifampicin,
isoniazid, pyrazinamide and streptomycin
for 4months followed by rifampicin and
pyrazinamide alone for 2months.
D. Six months of combination therapy: rifampicin,
isoniazid, pyrazinamide and ethambutol
for 4months followed by rifampicin and
pyrazinamide alone for 2months.
E. Six months of combination therapy: Rifampicin,
isoniazid, pyrazinamide and ethambutol for
4months followed by rifampicin and isoniazid
alone for 2months.
12. An 86-year-old man with a history of chronic
obstructive pulmonary disease (COPD) is brought
in to the emergency department from a nursing
home with acute onset shortness of breath. On
examination he is alert and maintaining his own
airway, but he is visibly in respiratory distress,
gasping for air, and using accessory muscles of
respiration with a respiratory rate of 36 per minute.
His temperature is 38.5°C. His oxygen saturations
are 88% on 15 L of oxygen through a non-rebreather
mask. He is tachycardic with a pulse of 110. His
blood pressure is 120/80 mmHg. What is the initial
treatment?
A. Continue with oxygen alone. Perform further
investigations before commencing other
treatment as management will depend on the
underlying diagnosis.
396

Single best answer (SBA) questions
B. Get senior help. Raise the edge of the bed.
Change the oxygen delivery system to a venturi
mask. Commence back-to-back nebulized
bronchodilator therapy and intravenously
administer hydrocortisone.
C. Get senior help. Raise the edge of the
bed. Commence back-to-back nebulized
bronchodilator therapy, intravenous fluids and
empirical antibiotics.
D. Bleep the anaesthetist so the patient can be
intubated.
E. Try simple manoeuvres to improve the
patient’s oxygenation such as raise the edge of
the bed and suction of excessive secretions.
Continue with oxygen and give nebulized
salbutamol. If there is no improvement, consider
intravenously administered magnesium and
hydrocortisone. Reassess the patient after every
intervention.
13. For the case in the previous question, what is the
least useful initial test that you could request?
A. Arterial blood gas (ABG).
B. Chest X-ray (CXR).
C. Full blood count, urea and electrolytes,
C-reactive protein.
D. CT pulmonary angiogram.
E. Urine dip.
14. A 63-year-old comes to the emergency department
with pleuritic chest pain and shortness of breath.
He returned from a trip to visit his family in Australia
2days ago. It was a long-haul flight lasting over 15
hours. A pulmonary embolism (PE) is suspected,
and a CT pulmonary angiogram is ordered. What
investigation should be performed before the scan
can take place?
A. Kidney function tests.
B. Chest X-Ray (CXR).
C. D-dimer.
D. Liver function tests.
E. V./Q. scan.
15. A 25-year-old goes to see her GP with a dry cough
and some shortness of breath. She has a fever and
feels generally unwell with flulike symptoms. She
returned from a summer holiday in Spain 6days
ago. She has a diagnosis of type 1 diabetes mellitus,
for which she has an insulin pump. She is a smoker.
Considering the history, what pathogen causing
pneumonia should you be worried about?
A. Streptococcus pneumoniae
B. Mycoplasma tuberculosis
C. Influenza virus
D. Legionella pneumophila
E. Methicillin-resistant Staphylococcus aureus
Chapter29 Gastrointestinal and
hepatobiliary systems
1. A 67-year-old man underwent an
oesophagogastroduodenoscopy (OGD) for reflux
symptoms. Barrett oesophagus was diagnosed.
Which one of the following statements regarding this
condition is true?
A. Approximately 25% of cases will progress to
adenocarcinoma.
B. The condition predominantly affects the middle
third of the oesophagus.
C. The condition is asymptomatic in most cases.
D. The condition is treated surgically in the first
instance.
E. The condition is characterized by dysplasia
from squamous cell epithelium to columnar cell
epithelium.
2. A 43-year-old midwife presents with constant,
epigastric pain radiating to the back. She had been
suffering with intermittent episodes of right upper
quadrant (RUQ) pain for the previous 6months.
Serum amylase level is 1400 U/mL. A diagnosis of
suspected pancreatitis is made. Which one of the
following statements is true?
A. A serum amylase level of more than 2500 U/mL
indicates severe pancreatitis.
B. The most likely cause is gallstones.
C. The Rockall score is used to assess severity.
D. A recognized early complication of pancreatitis is
pseudocyst formation.
E. Pancreatitis is the only possible diagnosis.
3. A 58-year-old person with alcoholism with known
cirrhosis presents with copious haematemesis.
A variceal bleed is suspected. Which one of the
following statements is true for the management of a
large upper gastrointestinal (GI) tract haemorrhage?
A. A detailed history and examination is a priority.
B. A large bleed causes an immediate decrease in
haemoglobin concentration.
C. A large bleed causes a decrease in urea
concentration.
D. The investigation of choice is a CT scan.
E. Rebleeding carries higher mortality.
4. A 24-year-old primary school teacher presents with
abdominal pain and bloody diarrhoea. He has a
colonoscopy which shows features of ulcerative
colitis (UC). Which one of the following features is
associated with UC?
A. Transmural inflammation.
B. Pseudopolyps.
C. Perianal lesions.
D. Skip lesions.
E. More common in smokers.
397
Соседние файлы в папке Библиотека им академика М.И. Перельмана
